|
|||||
|
|
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin) |
|
| Abstract: | |
| Keywords: | trastuzumab EMT SLUG SNAIL2 breast cancer cancer stem cells |
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |